ARQT

Arcutis Biotherapeutics, Inc. $23.89 1M -9.1% 3M -2.9% YTD -17.6% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
-0.6%
Next 1 month
-0.3%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 61
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.18%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.12 -0.2% · Seasonal tilt (5y) -0.1%
$46M/day volume 56% volatility +36% 1-year -42% from ATH
52-week range · 48% of the way up · -25% from the high
$16.57$31.77

Congressional trades in ARQT Full tracker →

2 members · 4 buys / 2 sells · $6K–$90K disclosed · latest filing Jun 8, 2026.

BUY GC Gilbert Cisneros · traded May 29, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Mar 3, 2026 $1K–$15K
SELL GC Gilbert Cisneros · traded Dec 11, 2025 $1K–$15K
SELL JG Josh Gottheimer · traded Sep 15, 2023 $1K–$15K
BUY JG Josh Gottheimer · traded Apr 17, 2023 $1K–$15K
BUY JG Josh Gottheimer · traded Jun 15, 2022 $1K–$15K

Earnings Full history →

Next report 2026-10-27 (Tuesday, after close, in 43 days) · EPS est. 0.16.

1-day std dev
11.0%
Finished up
59%
Biggest pop
+32.1%
Biggest drop
-18.8%

Standard deviation of the close-to-close move over the last 27 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.